Do antidepressants cause folic acid depletion? A pilot study

Area of Science:

• Nutritional Psychiatry
• Geriatric Medicine
• Pharmacology

Background:

• Chronic use of tricyclic antidepressants is prevalent in elderly psychiatric patients.
• Folic acid depletion is a potential adverse effect of certain medications, impacting mental health.
• Understanding drug-induced nutrient deficiencies is crucial for managing geriatric mental well-being.

Purpose of the Study:

• To investigate the impact of chronic medication use on folate and vitamin B12 levels in elderly psychiatric inpatients.
• To compare folate and vitamin B12 levels in patients receiving tricyclic antidepressants, antipsychotics, or anticonvulsants versus controls.
• To identify specific drug classes associated with nutrient depletion in this population.

Main Methods:

• Pilot study involving elderly psychiatric inpatients.
• Measurement of serum and red blood cell folate and serum vitamin B12 levels.
• Comparison of nutrient levels across four groups: controls, tricyclic antidepressants, phenothiazines (antipsychotics), and carbamazepine (anticonvulsant).

Main Results:

• Patients on prolonged phenothiazine or carbamazepine treatment showed lower serum and erythrocyte folate levels compared to controls.
• Phenothiazine use was significantly associated with decreased serum folate levels.
• Tricyclic antidepressants did not cause significant folate depletion within the first two years of treatment.

Conclusions:

• Antipsychotic (phenothiazine) and anticonvulsant (carbamazepine) therapies are associated with folate depletion in elderly psychiatric patients.
• Tricyclic antidepressants appear safe regarding folate levels in the short term (up to two years).
• Monitoring folate levels is recommended for elderly patients on phenothiazines or carbamazepine to prevent adverse mental health effects.